Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of the Treatment of Genital Warts by Low Dose Cyclophosphamide

NCT00999986 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT00999986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00999986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of the Treatment of Genital Warts by Low Dose Cyclophosphamide
Lead sponsor
Huazhong University of Science and Technology
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2007
Completion date
August 31, 2009
Enrollment
104 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genital wart